Literature DB >> 1967995

T lymphocyte interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected non-immune and low in immune subjects.

C Chizzolini1, G E Grau, A Geinoz, D Schrijvers.   

Abstract

Interferon (IFN) alpha and gamma were measured by radio-immunoassays in supernatants from cultures of peripheral blood mononuclear cells (PBMC) or purified T cell subsets incubated with either Plasmodium falciparum schizont-enriched malaria antigen (mAg), uninfected red blood cells (RBC) or pokeweed mitogen (PWM). Cell donors were 24 clinically immune, healthy African adult native residents of a P. falciparum-endemic region, Haut-Ogooué, Gabon, and seven non-immune, European temporary residents with a history of a single to a few malaria infections during the previous 1 to 9 months. When PBMC were cultured in medium alone or with RBC antigen no or low titres of IFN-gamma were detected. PBMC proliferation and IFN-gamma production observed in the presence of mAg were dose dependent and significantly correlated. When cultured with mAg, PBMC from non-immune Europeans produced significantly higher levels of IFN-gamma than did PBMC from clinically immune Africans. No such difference was found when PBMC were cultured with PWM. The mAg-induced IFN-gamma production was due mainly to CD4+ T cells and was not enhanced by CD8+ T cell depletion. No IFN-alpha was detected in culture supernatants. Thus, P. falciparum antigens are able to induce in vitro production of IFN-gamma by CD4+ T cells; however, in this sample, individuals considered to be clinically resistant to malaria were low producers of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967995      PMCID: PMC1534724          DOI: 10.1111/j.1365-2249.1990.tb05133.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Antigen-specific and MHC-restricted Plasmodium falciparum-induced human T lymphocyte clones.

Authors:  C Chizzolini; L Perrin
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

2.  Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.

Authors:  A Ferreira; L Schofield; V Enea; H Schellekens; P van der Meide; W E Collins; R S Nussenzweig; V Nussenzweig
Journal:  Science       Date:  1986-05-16       Impact factor: 47.728

3.  Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites.

Authors:  L Schofield; J Villaquiran; A Ferreira; H Schellekens; R Nussenzweig; V Nussenzweig
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

5.  Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages.

Authors:  C F Ockenhouse; S Schulman; H L Shear
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

6.  Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.

Authors:  G E Grau; L F Fajardo; P F Piguet; B Allet; P H Lambert; P Vassalli
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

7.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

8.  Cell-mediated immune responses to Plasmodium falciparum antigens in adult Gambians.

Authors:  E M Riley; S Jepsen; G Andersson; L N Otoo; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

9.  T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.

Authors:  L Kabilan; M Troye-Blomberg; H Perlmann; G Andersson; B Högh; E Petersen; A Björkman; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro.

Authors:  M Troye-Blomberg; G Andersson; M Stoczkowska; R Shabo; P Romero; M E Patarroyo; H Wigzell; P Perlmann
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  23 in total

1.  Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum malaria attack.

Authors:  C Chougnet; S Tallet; P Ringwald; P Deloron
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

2.  Macrophage activation in falciparum malaria as measured by neopterin and interferon-gamma.

Authors:  A E Brown; H K Webster; P Teja-Isavadharm; D Keeratithakul
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

3.  Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria.

Authors:  M S Rhee; B D Akanmori; M Waterfall; E M Riley
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  Reduced antibody response to the repetitive sequence of the Plasmodium falciparum circumsporozoite protein in mice infected with Plasmodium yoelii blood forms.

Authors:  D Grillot; A Pessi; A S Verdini; P H Lambert; G Del Giudice
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

5.  The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis.

Authors:  Sarah Hochman; Kami Kim
Journal:  J Neuroparasitology       Date:  2012-03-02

Review 6.  The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.

Authors:  K Artavanis-Tsakonas; J E Tongren; E M Riley
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

7.  Decreased serum levels of TGF-beta in patients with acute Plasmodium falciparum malaria.

Authors:  C Wenisch; B Parschalk; H Burgmann; S Looareesuwan; W Graninger
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

8.  Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria.

Authors:  P H Jakobsen; S Morris-Jones; T G Theander; L Hviid; M B Hansen; K Bendtzen; R G Ridley; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion.

Authors:  Z C Zeng; Z Y Tang; K D Liu; J Z Lu; X J Cai; H Xie
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

10.  Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.

Authors:  Arlene E Dent; Kiprotich Chelimo; Peter O Sumba; Michele D Spring; Brendan S Crabb; Ann M Moormann; Daniel J Tisch; James W Kazura
Journal:  Malar J       Date:  2009-07-16       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.